Patent · US Active

KRAS mutant protein inhibitors

US11787811B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

JACOBIO PHARMACEUTICALS CO., LTD. · CN

Inventors

Amin LI · Beijing, CN
Sujing Li · Beijing, CN
Peng Wang · Carlsbad, US
Chaojie Dang · Beijing, CN
Dan Liu · Beijing, CN

Key dates

Filing date	Aug 20, 2021
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Aug 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a KRAS mutant protein inhibitor shown as formula (I), a composition containing the inhibitor and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.